#atmps — Public Fediverse posts

🗞️ JUST PUBLISHED: IHI's June newsletter!
👉 https://lnkd.in/eJE7Ej6X
⚡ The topic texts of call 13 are approved!
📺 #IHICallDays - 3 to go!
📆 IHI Forum: 20-21 Oct save the date
🧬ARDAT is tackling regulatory science for #ATMPs
🧩 @aims2trials.bsky.social release data ethically for #AutismResearch
#HorizonEU

Belgium’s university-industry collaboration model could accelerate EU’s advanced therapeutics [Advocacy Lab Content] https://www.euractiv.com/section/health-consumers/news/belgiums-university-industry-collaboration-model-could-accelerate-eus-advanced-therapeutics/?utm_source=dlvr.it&utm_medium=mastodon #ATMPs #Belgium #EUPharmaPackage #promoted #therapeutics

EU needs to step up to unleash gene therapies potential, stakeholders say https://www.euractiv.com/section/health-consumers/news/eu-needs-to-step-up-to-unleash-gene-therapies-potential-stakeholders-say/?utm_source=dlvr.it&utm_medium=mastodon #ATMPs #genetherapies #rarediseases

Today I’m at the European Parliament, discussing cell & gene therapies, rather novel treatment options for terrible diseases. Incredible progress has been made by researchers!
The tricky bit: How medicines are regulated isn’t adapted to these novel types of treatments. Rules for clinical trials & approval don’t work well for #ATMPs.
Today experts are discussing which rules need to be adapted to bring these innovative treatments to patients faster.
#MEPsforATMPs #HorizonEurope #SciPol #HorizonEU

Are you an academic sponsor 🎓 or a non-profit organisation developing advanced therapy medicines? Are you seeking regulatory support? 💊💉

Join EMA’s pilot for European academic and non-profit developers of advanced therapy medicinal products (#ATMPs).

#research

🐦🔗: https://n.respublicae.eu/EMA_News/status/1608462844097429509